Valneva to Present and Hold Investor Meetings at the Guggenheim Vaccines and Infectious Disease Conference

NEXT STORY
Apellis Announces Detailed Results from Phase 3 DERBY and OAKS Studies Presented at Retina Society Annual Meeting
PREV STORY
Alpha Mannosidosis Market Overview Shows A Single Company Owning Almost 90% Share As Per The Business Research Company’s Alpha Mannosidosis Global Market Report 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

University of Missouri Health Care Selects Cerner for Revenue Cycle Management

KANSAS CITY, Mo., Feb. 28, 2018 (GLOBE NEWSWIRE) -- University of Missouri Health Care, ...

author_avatar
NASDAQ Market News

Renown HIV specialist Dr. Gary Blick Joins Immune Therapeutics Advisory Board

ORLANDO, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, ...

author_avatar
NASDAQ Market News

Foamix Reports Third Quarter 2015 Financial Results and Provides Business Update

REHOVOT, Israel, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix Pharmaceuticals"), ...

author_avatar
NASDAQ Market News